The Effects of Simple Interventions on Tooth Mortality: Findings in One Trial and Implications for Future Studies

Abstract

The purpose of this report was to use a particular clinical trial, the Preventive Geriatric Trial (PGT), as a starting point to discuss whether treatment efficacy can be evaluated by means of tooth mortality. In the PGT, 296 subjects were recruited and randomly assigned to five treatment groups: (1) usual procedures (UP); (2) UP + a cognitive-behavioral intervention (CB); (3) UP + CB + weekly chlorhexidine rinse (CHX); (4) UP + CB + CHX + semi-annual fluoride varnish (F); and (5) UP + CB + CHX + F + semi-annual prophylaxis, including scaling (P). Exploratory analyses revealed that tooth mortality after the 1st year was lower in treatment groups 3, 4, and 5 than in groups 1 and 2. A one-year exposure resulted in a 45% reduction in tooth mortality (p < 0.05); a two-year exposure resulted in a 59% reduction (p-value < 0.04). The PGT findings suggested that it is possible to design trials based on clinically relevant endpoints, such as tooth mortality. For the detection of moderate treatment effects, such trials could take the form of Large, Simple Trials (LST), where many subjects are recruited with minimally restrictive entry criteria, and data are collected only on essential baseline characteristics and tooth mortality. LSTs have provided "reliable answers to important clinical questions" for other chronic diseases, and several arguments suggest that they could play a similar critical role in dental research: (1) Periodontitis and caries are among the most common and costly chronic diseases affecting humans, and the identification of even moderately effective treatments by LSTs can have a large socio-economic impact; (2) the identification of low-cost widely practicable treatments that lend themselves to be investigated in LSTs is likely to benefit more people than the identification of high-cost complex treatments; and (3) tooth mortality is simple to assess and more relevant than the unvalidated surrogate endpoints that have largely failed for more than 20 years to provide reliable answers to certain controversial issues regarding treatment efficacy. The cost of not reliably establishing the safety and the efficacy of treatments may be far greater than the cost of conducting LSTs.

Keywords

randomized controlled trials geriatrics tooth mortality surrogates.

Get full access to this article

View all access options for this article.

References

Ainamo J. (1983). The monitoring process and its importance for achievement of the global goals for oral health by the year 2000. Int Dent J 33:79-89.

Avioli LV (1991). Significance of osteoporosis: a growing international health care problem. Calcif Tissue Int 49:S5-S7.

Bader JD , Shugars DA (1995). Variation in dentists' clinical decisions. J Public Health Dent 55:181-188.

Breslow NE , Day NE (1987). Statistical methods in cancer research. Vol. II. The design and analysis of cohort studies. Oxford: Oxford University Press.

Cherry Peppers G. , Sinkford JC , Newman ES , Sanders CF , Knight RS (1995). Primary oral health care in black Americans: an assessment of current status and future needs. J Natl Med Assoc 87:136-140.

Chrischilles E. , Shireman T. , Wallace R. (1994). Costs and health effects of osteoporotic fractures . Bone 15:377-386.

Cox DR (1972). Regression models and life tables (with discussion) . J R Statist Soc 34(Series B):187-220.

Dobkin B. (1995). The economic impact of stroke. Neurology 45:56-59.

Drake CW , Hunt RJ , Koch GG ( 1995). Three-year tooth loss among black and white older adults in North Carolina. J Dent Res 74:675-680.

10.

Eklund SA , Burt BA ( 1994). Risk factors for total tooth loss in the United States; longitudinal analysis of national data. J Public Health Dent 54:5-14.

11.

Elixhauser A. (1991). Costs of breast cancer and the cost-effectiveness of breast cancer screening. Int j J Technol Assess Health Care 7:604-615.

12.

Fdi (1982a). Global goals for oral health in the year 2000. Int Dent J 32:74-77.

13.

Fdi (1982b). Goals for oral health in the year 2000. Br Dent J 152:21-22.

14.

Fdi (1982c). Goals for oral health in the year 2000. Rev Fed Odontol Colomb 30:58-62.

15.

Fdi (1983). Objectives for orodental health for the year 2000. Riv Ital Stomatol 52:199-204.

16.

Feldman RS , Alman JE , Chauncey HM (1986). Design and analysis considerations for a longitudinal study of periodontal disease. J Clin Periodontol 13:506-510.

17.

Fleming T. (1992). Evaluating therapeutic interventions: some issues and experiences. Stat Sci 7:428-456.

18.

Fleming T. (1990). Evaluation of active control trials in AIDS. J AIDS 3:S82-S87.

19.

Fleming T. (1994). Surrogate markers in AIDS and cancer trials. Stat Med 13:1423-35.

20.

Hellinger FJ (1992). Forecasts of the costs of medical care for persons with HIV: 1992-1995. Inquiry 29:356-365.

21.

Hujoel PP (1995). Definitive vs. exploratory periodontal trials: a survey of published studies. J Dent Res 74:1453-1459.

22.

Hujoel PP , DeRouen TA (1995). A survey of endpoint characteristics in periodontal clinical trials published 1988-1992, and implications for future studies. J Clin Periodontol 22:397-407.

23.

Hujoel PP , Leroux BG , DeRouen TA , Powell LV , Kiyak HA (1997). Evaluating the validity of probing attachment mortality in a clinical trial on the elderly. J Dent Res 76:858-866.

24.

Kelsey C (1996). The dean who never was. DentalUM 12:7. Klippel JH (1990). Winning the battle, losing the war? Another editorial about rheumatoid arthritis. J Rheumatol 17:1118-1122. Levit KR (1994). National health expenditures, 1993. Health Care Financ Rev 16:247-294.

25.

Liang K. -Y, Zeger SL (1986). Longitudinal data analysis using generalized linear models. Biometrika 73:13-22.

26.

Liberman UA , Weiss SR , Broll J. , Minne HW , Quan H. , Bell NH , et al. (1995). Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase IV Osteoporosis Treatment Study Group. N Engl J Med 333:1437-1443.

27.

Lindsay R. (1995). The burden of osteoporosis: cost. Am J Med 98:9S-11S.

28.

Marcus SE , Kaste LM , Brown LJ (1994). Prevalence and demographic correlates of tooth loss among the elderly in the United States. Spec Care Dentist 14:123-127.

29.

Melton LJ 3rd (1993). Hip fractures: a worldwide problem today and tomorrow . Bone 1:S1-S8.

30.

Nabers CL , Stalker WH , Esparza D. , Naylor B. , Canales S. (1988). Tooth loss in 1535 treated periodontal patients . J Periodontol 59:297-300.

31.

Norris RJ (1992). Medical costs of osteoporosis. Bone 2:S11-S16. Nowak R (1994). Problems in clinical trials go far beyond misconduct [news]. Science 264:1538-1541.

32.

Peto R. , Collins R. , Gray R. ( 1993). Large-scale randomized evidence: Large simple trials and overviews of trials. In: Doing more good than harm. The evaluation of health care interventions. Vol. 703. Warren KS , Mosteller F , editors. New York: The New York Academy of Sciences, pp. 314-340.

33.

Pocock SJ (1983). Clinical trials: a practical approach. New York: Wiley.

34.

Probstfield JL , Wittes JT , Hunninghake DB (1987). Recruitment in NHLBI population-based studies and randomized clinical trials: data analysis and survey results. Controlled Clin Trials 8:1415-1495.

35.

Report of the Committee of Principal Investigators (1984). WHO cooperative trial on primary prevention of ischaemic heart disease with clofibrate to lower serum cholesterol: final mortality follow-up. Lancet 2:600-604.

36.

Riggs BL , Hodgson SF , O'Fallon WM , Chao EY , Wahner HW , Muhs JM , et al. (1990). Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis [see comments]. N Engl J Med 322:802-809. Comments in: N Engl J Med 322:845-868 (1990), 323:416-417 (1991).

37.

Roccella EJ , Lenfant C. (1992). Considerations regarding the cost and effectiveness of public and patient education programmes. J Hum Hypertens 6:463-467.

38.

Signorini DF (1991). Sample size for Poisson regression. Biometrika 78:446-450.

39.

Silverman WA (1993). Doing more good than harm. In: Doing more good than harm: the evaluation of health care interventions. Vol. 703. New York: The New York Academy of Sciences, pp. 5-11.

40.

Wall CH ( 1984). Oral health status and tradition in Australia. Int Dent J 34:271-277.

41.

Wei LY , Lin DY , Weissfeld L. (1989). Regression analysis of multivariate incomplete failure time data by modeling marginal distributions. J Am Statist Assoc 84:1065-1073.

42.

Yusuf S. , Collins R. , Peto R. ( 1984). Why do we need some large, simple randomized trials? Stat Med 3:409-422.